Prévisions du marché des tests développés en laboratoire au Moyen-Orient et en Afrique jusqu’en 2028 – Impact du COVID-19 et analyse régionale par type (biochimie clinique, soins intensifs, hématologie, microbiologie, diagnostics moléculaires, immunologie et autres types de tests) et application (instituts universitaires, recherche clinique (Organisations, Laboratoires Hôpitaux, Centres de Diagnostic Spécialisés et Autres)
Introduction au marché
Un test développé en laboratoire (LDT) est un type de test de diagnostic in vitro conçu et utilisé dans un seul laboratoire. Ces tests peuvent être utilisés pour estimer ou distinguer un vaste assortiment d’analytes tels que des protéines, des composés chimiques comme le glucose ou le cholestérol, ou de l’ADN, à partir d’un échantillon provenant de l’anatomie humaine. L\'expansion des méthodes automatisées de diagnostic in vitro (IVD) pour les laboratoires et les dispensaires afin de fournir des analyses précises et sans erreur devrait alimenter cette augmentation.
Aperçu et dynamique du marché
Le marché des tests développés en laboratoire au Moyen-Orient et en Afrique devrait atteindre les États-Unis 869,59 millions de dollars d’ici 2028 contre 577,05 millions de dollars en 2021 ; on estime qu’il connaîtra une croissance de 7,0 % entre 2021 et 2028. La recherche continue sur la médecine personnalisée et l’automatisation croissante des processus de laboratoire à travers le monde sont des facteurs qui propulsent le marché des tests développés en laboratoire. Cependant, l’évolution du paysage réglementaire entrave la croissance du marché des tests de développement de laboratoires au Moyen-Orient et en Afrique.
Les LDT jouent un rôle essentiel dans le développement de médicaments personnalisés qui sont susceptibles de s\'avérer comme des moyens prometteurs de lutter contre des maladies grâce à des traitements ou des remèdes efficaces jusqu\'à présent ignorés. Selon la Personalized Medicine Coalition, les médicaments personnalisés ne représentaient que 5 % des nouvelles entités moléculaires approuvées par la FDA en 2005 ; cependant, en 2016, ce chiffre est passé à plus de 25 %. De plus, 42 % de tous les composés et 73 % des composés oncologiques en cours de développement ont le potentiel de servir de médicaments personnalisés. Les sociétés biopharmaceutiques ont presque doublé leurs investissements en R&D dans les médicaments personnalisés au cours des cinq dernières années à travers le monde. Ils devraient en outre augmenter leurs investissements de 33 % au cours des cinq prochaines années. Les chercheurs biopharmaceutiques prédisent également une augmentation de 69 % du développement de médicaments personnalisés au cours des cinq prochaines années. Les médecines personnalisées sont en train de devenir la marque de fabrique du traitement du cancer ; il s\'agit d\'une approche en constante évolution basée sur la personnalisation des traitements en fonction de la structure génétique individuelle. En 2019, la FDA a approuvé 12 médicaments personnalisés pour étudier et traiter les causes profondes des maladies : combinant ainsi la médecine de précision aux soins cliniques. La demande croissante de médecine personnalisée offre donc des opportunités de croissance significatives aux acteurs opérant sur le marché des tests développés en laboratoire MEA. En outre, l\'automatisation apparaît comme une approche visant à minimiser l\'implication humaine dans les processus de laboratoire, stimulant ainsi la croissance du marché.
Les incertitudes économiques et les conflits en cours aggravent la situation au Moyen-Orient. Par exemple, des pays comme la Syrie, la Libye et le Yémen sont confrontés à un conflit violent et sont incapables de mettre en œuvre des mesures de santé publique. Une baisse soudaine de la demande intérieure et extérieure de biens et de produits, en particulier de pétrole brut, et l\'arrêt de la production en raison d\'une pénurie de main-d\'œuvre sont des impacts importants observés dans la région. De plus, le resserrement des conditions financières diminue les activités économiques au Moyen-Orient. Cela a donc un impact négatif sur la croissance des tests développés en laboratoire dans la région.
Marché clé Segments
Le marché des tests développés en laboratoire au Moyen-Orient et en Afrique, par type, est segmenté en biochimie clinique, soins intensifs, hématologie, microbiologie, diagnostic moléculaire, immunologie, et d\'autres types de tests. Le segment hématologie a été sous-segmenté en coagulation et hémostase, tests d\'hémoglobine, tests de formule sanguine et autres. Le segment du diagnostic moléculaire détenait la plus grande part du marché en 2021. Cependant, le segment de l\'hématologie devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.
Le Moyen-Orient et l\'Afrique Le marché des tests développés en laboratoire, par application, est segmenté en instituts universitaires, organismes de recherche clinique, laboratoires hospitaliers, centres de diagnostic spécialisés et autres. Le segment des laboratoires hospitaliers détenait la plus grande part du marché en 2021. Cependant, le segment des centres de diagnostic spécialisés devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.
Principales sources et sociétés répertoriées
Quelques-unes des Les sources primaires et secondaires mentionnées lors de la préparation du rapport sur le marché des tests développés en laboratoire au Moyen-Orient et en Afrique sont la South Africa Medical Devices Association (SAMED), la SA Health Products Regulatory Authority (SAHPRA) et le Centre international de recherche sur le cancer (CIRC). /span>
Raisons d\'acheter le rapport
- Déterminer les domaines d\'investissement potentiels sur la base d\'une analyse détaillée des tendances du Marché des tests développés en laboratoire au Moyen-Orient et en Afrique span>au cours des prochaines années.
- Acquérir une compréhension approfondie des facteurs sous-jacents à l\'origine de la demande pour différents thérapeutiques contre les dépendances dans les pays les plus dépensiers et identifiez les opportunités offertes par chacun d\'eux.
- Renforcez votre connaissance du marché en termes de moteurs de la demande, de tendances du secteur et les derniers développements technologiques, entre autres.
- Identifier les principaux canaux qui animent le Le marché des tests développés en laboratoire au Moyen-Orient et en Afrique , fournissant une image claire des opportunités futures qui faciliteront l\'analyse, ce qui entraînera une augmentation des revenus.
- Canaliser les ressources en se concentrant sur les programmes en cours entrepris par le différents pays du Marché des tests développés en laboratoire au Moyen-Orient et en Afrique.
< span>
LE LABORATOIRE DU MOYEN-ORIENT ET DE L\'AFRIQUE A DÉVELOPPÉ LA SEGMENTATION DU MARCHÉ DES TESTS
Par type
- Biochimie clinique
- Soins intensifs
- Hématologie
- Coagulation et hémostase,
- < span>Tests d\'hémoglobine
- Tests de numération sanguine
- Autres
- Immunologie
- Microbiologie
- Diagnostic moléculaire
- Autres types de tests
Par Application
- Instituts universitaires
- Organisations de recherche clinique
- Laboratoire des hôpitaux
- Centres de diagnostic spécialisés
- Autres
Par pays
- EAU
- Arabie Saoudite
- Afrique du Sud
- Reste du Moyen-Orient et Afrique
Profils d\'entreprise
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Rosetta Genomics Ltd.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Laboratory Developed Test Market – By Type
1.3.2 Middle East and Africa Laboratory Developed Test Market – By Application
1.3.3 Middle East and Africa Laboratory Developed Test Market – By Country
2. Laboratory Developed Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Laboratory Developed Test Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa – PEST Analysis
4.3 Experts Opinion
5. Laboratory Developed Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Cancer and Genetic Disorders
5.1.2 Large Number of Product Launches
5.2 Market Restraints
5.2.1 Changing Regulatory Landscape
5.3 Market Opportunities
5.3.1 Continuous Research on Personalized Medicine
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact Analysis
6. Laboratory Developed Test Market –Middle East and Africa Analysis
6.1 Middle East and Africa Laboratory Developed Test Market Revenue Forecast and Analysis
7. Laboratory Developed Test Market Analysis – By Type
7.1 Overview
7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
7.3 Clinical Biochemistry
7.3.1 Overview
7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Haematology
7.4.1 Overview
7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Coagulation and Hemostasis
7.4.3.1 Overview
7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Hemoglobin Testing
7.4.4.1 Overview
7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Blood Count Testing
7.4.5.1 Overview
7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Immunology
7.5.1 Overview
7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Critical Care
7.6.1 Overview
7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Microbiology
7.7.1 Overview
7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Molecular Diagnostics
7.8.1 Overview
7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Other Test Types
7.9.1 Overview
7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8. Laboratory Developed Test Market Analysis – By Application
8.1 Overview
8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Clinical Research organizations
8.4.1 Overview
8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hospital laboratory
8.5.1 Overview
8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Diagnostic Centers
8.6.1 Overview
8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
9. Laboratory Developed Test Market – Middle East and Africa Analysis
9.1 Middle East and Africa: Laboratory Developed Test Market
9.1.1 Overview
9.1.2 Middle East & Africa: Laboratory Developed Test Market- Revenue and Forecast to 2028 (US$ Million)
9.1.3 Middle East and Africa Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.3.1 Middle East and Africa: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.4 Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5 Middle East and Africa: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
9.1.5.1 Saudi Arabia: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 Saudi Arabia: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2 Saudi Arabia Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2.1 Saudi Arabia: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.1.3 Saudi Arabia Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.2 UAE: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 UAE: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2 UAE Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2.1 UAE: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.2.3 UAE Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.3 South Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 South Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2 South Africa Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2.1 South Africa: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.3.3 South Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.4 Rest of Middle East and Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.4.1 Rest of Middle East and Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.4.2 Rest of Middle East and Africa Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.4.2.1 Rest of Middle East and Africa: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.4.3 Rest of Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Middle East and Africa Laboratory Developed Test Market
10.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11. Laboratory Developed Test Market–Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F.HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.6 Rosetta Genomics Ltd.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 The company’s financial information is not available in the public domain.
12.6.6 SWOT Analysis
12.6.7 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Middle East and Africa Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Middle East and Africa Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of Middle East and Africa Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market
Table 17. Recent Organic Growth Strategies in the Laboratory Developed Test Market
Table 18. Glossary of Terms, Laboratory Developed Test Market
LIST OF FIGURES
Figure 1. Laboratory Developed Test Market Segmentation
Figure 2. Laboratory Developed Test Market Segmentation, By Country
Figure 3. Middle East and Africa Laboratory Developed Test Market Overview
Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market
Figure 5. Middle East and Africa Laboratory Developed Test Market – Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa PEST Analysis
Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints
Figure 2. Middle East and Africa Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028
Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Middle East and Africa: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Middle East & Africa Laboratory Developed Test Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East and Africa: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
Figure 24. Saudi Arabia: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. UAE: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. South Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of Middle East and Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Rosetta Genomics Ltd.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa laboratory developed test market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.